Pear Therapeutics Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- Pear Therapeutics's estimated annual revenue is currently $51.3M per year.
- Pear Therapeutics received $64.0M in venture funding in January 2019.
- Pear Therapeutics's estimated revenue per employee is $270,000
- Pear Therapeutics's total funding is $134M.
- Pear Therapeutics has 190 Employees.
- Pear Therapeutics grew their employee count by 5% last year.
- Pear Therapeutics currently has 23 job openings.
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Pricing|
|Child and Famil...||$21.9M||81||7%||N/A||N/A|
|The Brien Cente...||$50.5M||187||9%||N/A||N/A|
|The Brookline C...||$11.3M||42||8%||N/A||N/A|
|RIVER VALLEY CO...||$27.5M||102||6%||N/A||N/A|
What Is Pear Therapeutics?
At Pear, our mission is clear: we are pioneers in Prescription Digital Therapeutics, or PDTs. Our cross-functional team operates at the intersection of biotechnology and software technology. Pear discovers, develops, and delivers clinically-validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Every day, we push the boundaries of technology to transform medicine. Pear has a pipeline of products and product candidates across therapeutic areas, including mental health disorders, severe insomnia and multiple sclerosis. Our lead product, reSET®, treats Substance Use Disorder, and was the first PDT to receive marketing authorization from the FDA to treat disease. Pear's second product candidate, reSET-O for the treatment of Opioid Use Disorder, is currently under review by the FDA with Breakthrough Designation. For more information, visit us at www.peartherapeutics.com.keywords:Biotechnology,Gaming,Healthcare,Human Resources Hr,Information Security,Medical Diagnostics,Mobile,Pharmaceuticals,Security
Number of Employees
Employee Growth %
|Michael Pace||VP, Market Access, Value & Evidence||Email Available|
|Brian Prunier||VP Patient Services||Email Available|
|Joy Patermo||Regional Business Director||Email Available|
|Lin Song||Director Of Software||Email Available|
|Jordie Valdes||Director Of Marketing||Email Available|
|Kristin Nienhuis||Operations Manager|
|Travis Blount||Regional Business Director||Email Available|
|Hilary Luderer||Director Of Translational And Clinical Research||Email Available|
|Holly Webb||Director of Software Quality Assurance||Email Available|
|Michael Furgason||Senior Product Manager||Email Available|
Pear Therapeutics News
Several companies, including Pear Therapeutics and Dthera, are taking a wildly different approach: digital therapeutics. These are pieces of ...
Global Digital Therapeutic Devices Market 2023 by Growth Factors, ... Virta Health, Pear Therapeutics, BioTelemetry, Blue Mesa Health, M&A ...
Global Digital Therapeutics and Their Impact on Healthcare Market 2019-2026 | Top key players are Big Health,Pear Therapeutics,Kaia Health ...
Pear Therapeutics Funding